gold has been researched along with isoniazid in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (6.90) | 18.7374 |
1990's | 3 (10.34) | 18.2507 |
2000's | 2 (6.90) | 29.6817 |
2010's | 20 (68.97) | 24.3611 |
2020's | 2 (6.90) | 2.80 |
Authors | Studies |
---|---|
Jacobsen, CD | 1 |
Cowie, RL | 1 |
Hoeppner, VH | 1 |
Churchyard, GA; Kleinschmidt, I; Mqoqi, NP; Williams, B | 1 |
Chaisson, RE; Charalambous, S; Churchyard, GJ; Corbett, EL; Day, JH; De Cock, KM; Fielding, K; Grant, AD; Hayes, RJ; Samb, B | 1 |
Charalambous, S; Churchyard, GJ; Day, JH; Fielding, KL; Grant, AD; Hayes, RJ | 1 |
Jena, BK; Raj, CR | 1 |
Chaisson, RE; Churchyard, GJ; Corbett, EL; Fielding, KL; Grant, AD; Hayes, RJ | 1 |
Beylis, N; Chihota, VN; Churchyard, GJ; Dorman, SE; Fielding, KL; Grant, AD; Lewis, JJ; Mathema, B; van der Meulen, M | 1 |
Chihota, VN; Churchyard, GJ; Fielding, KL; Grant, AD; Lewis, JJ; van Halsema, CL | 1 |
Du, J; Liu, X; Lu, X; Wang, Z; Wu, B; Xue, Z; Zhou, X | 1 |
Hatamie, A; Zargar, B | 1 |
Chihota, VN; Churchyard, GJ; Coetzee, L; Fielding, KL; Grant, AD; Lewis, JJ; Luttig, M; Muller, D; Popane, F | 1 |
Chaisson, RE; Churchyard, GJ; Coetzee, L; Corbett, EL; Fielding, KL; Godfrey-Faussett, P; Grant, AD; Hayes, RJ; Lewis, JJ | 1 |
Baptista, PV; Couto, I; Machado, D; Pedrosa, P; Veigas, B; Viveiros, M | 1 |
Yaqub, F | 1 |
Aydin Teke, T; Bayhan, Gİ; Metin Timur, Ö; Öz, FN; Tanir, G; Tuygun, N | 1 |
Churchyard, GJ; Corbett, EL; Cox, AP; Fielding, KL; Grant, AD; Hayes, RJ; Lewis, JJ; Sumner, T; Vynnycky, E; White, RG | 1 |
Ehrlich, R; Oni, T | 1 |
Guo, Z; Huang, GQ; Li, MM; Wang, HH; Wang, ZY | 1 |
Chihota, V; Churchyard, GJ; Fielding, KL; Grant, AD; Hermans, SM; Lewis, JJ; Vynnycky, E | 1 |
Adikaram, CP; De Silva, KMN; Karunaratne, RE; Perera, J; Wijenayaka, LA; Wijesundera, SS | 1 |
Li, Y; Sun, J; Xia, Y; Zhao, XE; Zhu, S; Zuo, YN | 1 |
Bibb, C; Campbell, RD | 1 |
Ambrosone, A; de la Fuente, JM; Hernandez, Y; Hobmayer, B; Marchesano, V; Salvenmoser, W; Tino, A; Tortiglione, C | 1 |
Ambrosone, A; de la Fuente, JM; del Pino, P; Marchesano, V; Parak, WJ; Tortiglione, C | 1 |
Ambrosone, A; Carregal-Romero, S; Intartaglia, D; Marchesano, V; Parak, WJ; Tortiglione, C | 1 |
Brown, T; El-Sagheer, AH; Kanaras, AG; Kyriazi, ME; Moros, M; Tortiglione, C | 1 |
Ferraro, P; Lewinska, A; Merola, F; Moros, M; Tino, A; Tortiglione, C; Wnuk, M | 1 |
4 trial(s) available for gold and isoniazid
Article | Year |
---|---|
Short course chemoprophylaxis with rifampicin, isoniazid and pyrazinamide for tuberculosis evaluated in gold miners with chronic silicosis: a double-blind placebo controlled trial.
Topics: Adult; Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Follow-Up Studies; Gold; Humans; Isoniazid; Male; Middle Aged; Mining; Pyrazinamide; Rifampin; Silicotuberculosis | 1996 |
Thibela TB: design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa.
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Female; Gold; HIV Infections; Humans; Incidence; Isoniazid; Male; Mining; Prevalence; Pyridoxine; Randomized Controlled Trials as Topic; Research Design; Silicosis; South Africa; Tuberculosis, Pulmonary; Vitamin B Complex | 2011 |
A trial of mass isoniazid preventive therapy for tuberculosis control.
Topics: Adult; Antitubercular Agents; Epidemics; Gold; Humans; Incidence; Isoniazid; Male; Mass Screening; Medication Adherence; Mining; South Africa; Treatment Failure; Tuberculosis | 2014 |
Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy.
Topics: Adult; Antitubercular Agents; Gold; HIV Infections; Humans; Isoniazid; Middle Aged; Mining; Models, Theoretical; Public Health Practice; South Africa; Tuberculosis | 2015 |
25 other study(ies) available for gold and isoniazid
Article | Year |
---|---|
[Drug-induced anemias].
Topics: Adrenal Cortex Hormones; Anemia; Barbiturates; Bone Marrow; Chloramphenicol; Chlorpromazine; Dihydroxyphenylalanine; Gastrointestinal Hemorrhage; Gold; Humans; Hypoglycemic Agents; Indomethacin; Isoniazid; Nitrofurantoin; Phenacetin; Phenylbutazone; Phenytoin; Quinidine; Quinine; Salicylates; Sulfonamides | 1970 |
Short-course chemoprophylaxis evaluated in gold miners with chronic silicosis.
Topics: Antitubercular Agents; Gold; Humans; Isoniazid; Mining; Patient Compliance; Pyrazinamide; Rifampin; Silicosis; Treatment Outcome; Tuberculosis | 1997 |
Attendance versus compliance with tuberculosis treatment in an occupational setting--a pilot study.
Topics: Antibiotics, Antitubercular; Chi-Square Distribution; Cross-Sectional Studies; Drug Monitoring; False Positive Reactions; Gold; Humans; Isoniazid; Mining; Patient Compliance; Pilot Projects; Prevalence; Rifampin; South Africa; Tuberculosis, Pulmonary | 1997 |
Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?
Topics: Adult; Age Distribution; Antitubercular Agents; Black People; CD4 Lymphocyte Count; Cohort Studies; Gold; HIV Infections; Humans; Incidence; Isoniazid; Male; Middle Aged; Mining; Occupational Diseases; Secondary Prevention; South Africa; Tuberculosis | 2003 |
Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa.
Topics: Adult; Antitubercular Agents; Cross-Sectional Studies; Gold; HIV Infections; Humans; Isoniazid; Male; Mass Screening; Mining; Prevalence; Radiography, Thoracic; Sensitivity and Specificity; South Africa; Surveys and Questionnaires; Tuberculosis, Pulmonary | 2006 |
Au nanoparticle decorated silicate network for the amperometric sensing of isoniazid.
Topics: Antitubercular Agents; Electrochemistry; Gold; Hydrazines; Isoniazid; Linear Models; Metal Nanoparticles; Oxidation-Reduction; Sensitivity and Specificity; Silicates | 2010 |
Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Cross-Sectional Studies; DNA-Directed RNA Polymerases; Female; Genotype; Gold; Humans; Isoniazid; Male; Middle Aged; Mining; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; South Africa; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2012 |
Trends in drug-resistant tuberculosis in a gold-mining workforce in South Africa, 2002-2008.
Topics: Adult; Antitubercular Agents; Gold; HIV Infections; Humans; Isoniazid; Middle Aged; Mining; Mycobacterium tuberculosis; Prevalence; Rifampin; Risk Factors; South Africa; Tuberculosis, Multidrug-Resistant | 2012 |
A novel molecularly imprinted electrochemiluminescence sensor for isoniazid detection.
Topics: Acrylamides; Chemistry Techniques, Analytical; Electrochemistry; Electrodes; Glass; Gold; Hydrogen-Ion Concentration; Isoniazid; Luminescent Measurements; Metal Nanoparticles; Molecular Imprinting; Nanotubes, Carbon; Organometallic Compounds | 2012 |
Localized surface plasmon resonance of gold nanoparticles as colorimetric probes for determination of Isoniazid in pharmacological formulation.
Topics: Antitubercular Agents; Colorimetry; Gold; Isoniazid; Limit of Detection; Metal Nanoparticles; Pharmaceutical Preparations; Spectrophotometry; Surface Plasmon Resonance | 2013 |
Eligibility for isoniazid preventive therapy in South African gold mines.
Topics: Adult; Antitubercular Agents; Cross-Sectional Studies; Female; Gold; Humans; Isoniazid; Male; Middle Aged; Mining; Tuberculosis | 2013 |
Gold nanoprobes for multi loci assessment of multi-drug resistant tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; DNA-Directed RNA Polymerases; Early Diagnosis; Gold; Humans; Isoniazid; Metal Nanoparticles; Multiplex Polymerase Chain Reaction; Oxidoreductases; Point Mutation; Point-of-Care Systems; Rifampin; Tuberculosis, Multidrug-Resistant | 2014 |
Effectiveness of tuberculosis preventive therapy in gold miners.
Topics: Antitubercular Agents; Gold; Humans; Isoniazid; Mining; Occupational Diseases; Tuberculosis | 2014 |
Comparison of QuantiFERON-TB gold in-tube test with tuberculin skin test in children who had no contact with active tuberculosis case.
Topics: Adolescent; Antitubercular Agents; BCG Vaccine; Child; Child, Preschool; False Positive Reactions; Female; Gold; Humans; Infant; Interferon-gamma Release Tests; Isoniazid; Latent Tuberculosis; Male; Tuberculin Test | 2014 |
Complicated silicotuberculosis in a South African gold miner: A case report.
Topics: Antitubercular Agents; Continuity of Patient Care; Dust; Gold; Humans; Isoniazid; Male; Middle Aged; Miners; Mining; Mycobacterium Infections, Nontuberculous; Occupational Exposure; Pneumothorax; Post-Exposure Prophylaxis; Pulmonary Disease, Chronic Obstructive; Silicon Dioxide; Silicotuberculosis; South Africa | 2015 |
Electrochemical sensor for Isoniazid based on the glassy carbon electrode modified with reduced graphene oxide-Au nanomaterials.
Topics: Biosensing Techniques; Carbon; Conductometry; Equipment Design; Equipment Failure Analysis; Glass; Gold; Graphite; Isoniazid; Metal Nanoparticles; Microelectrodes; Nanocomposites; Oxidation-Reduction; Oxides; Reproducibility of Results; Sensitivity and Specificity | 2015 |
The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.
Topics: Adult; Antitubercular Agents; Cohort Studies; Disease-Free Survival; Drug Resistance, Bacterial; Female; Gold; Humans; Incidence; Isoniazid; Male; Middle Aged; Miners; Mycobacterium tuberculosis; Prevalence; Prospective Studies; Risk Factors; South Africa; Tuberculosis | 2016 |
Use of nanotechnology for infectious disease diagnostics: application in drug resistant tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Communicable Diseases; DNA, Bacterial; Gold; Humans; Isoniazid; Limit of Detection; Metal Nanoparticles; Multiplex Polymerase Chain Reaction; Mycobacterium tuberculosis; Nanotechnology; Sri Lanka; Tuberculosis, Multidrug-Resistant | 2019 |
Cascade amplification strategy combined with analyte-triggered fluorescence switching of dual-quenching system for highly sensitive detection of isoniazide.
Topics: Fluorescence; Gold; Isoniazid; Manganese Compounds; Metal Nanoparticles; Oxides | 2022 |
Tissue healing and septate desmosome formation in hydra.
Topics: Animals; Cell Adhesion; Colloids; Desmosomes; Epithelial Cells; Gold; Hydra; Microscopy; Microscopy, Electron; Transplantation, Homologous; Wound Healing | 1973 |
Imaging inward and outward trafficking of gold nanoparticles in whole animals.
Topics: Animals; Biological Transport, Active; Endosomes; Exocytosis; Exosomes; Genes, myc; Gold; Hydra; Kinetics; Metal Nanoparticles; Microscopy, Electron, Transmission; Nanoconjugates; Nanotechnology; Polyethylene Glycols; RNA, Small Interfering; Vacuoles | 2013 |
Gold nanoprisms for photothermal cell ablation in vivo.
Topics: Ablation Techniques; Animals; Cell Line, Tumor; Gene Expression Regulation; Gold; HSP70 Heat-Shock Proteins; Humans; Hydra; Hyperthermia, Induced; Metal Nanoparticles | 2014 |
Control of Wnt/β-Catenin Signaling Pathway in Vivo via Light Responsive Capsules.
Topics: Animals; beta Catenin; Cell Line; Drug Delivery Systems; Drug Liberation; Fluorescent Dyes; Gold; Hydra; Light; Metal Nanoparticles; Nanocapsules; Optical Imaging; Optogenetics; Particle Size; Polyelectrolytes; Signal Transduction; Surface Properties; Wnt Proteins | 2016 |
DNA-Coated Gold Nanoparticles for the Detection of mRNA in Live Hydra Vulgaris Animals.
Topics: Animals; Carbocyanines; DNA; Gold; Hydra; Metal Nanoparticles; Microscopy, Fluorescence; Oligonucleotides; Proto-Oncogene Proteins c-myc; RNA, Messenger | 2019 |
Gold Nanorods and Nanoprisms Mediate Different Photothermal Cell Death Mechanisms In Vitro and In Vivo.
Topics: Animals; Apoptosis; Cell Death; Cell Line, Tumor; Gold; Humans; Hydra; Hyperthermia, Induced; Melanoma; Metal Nanoparticles; Nanotubes; Necrosis; Photothermal Therapy; Surface Plasmon Resonance | 2020 |